These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6606829)

  • 21. [Sudden death in Chagas' disease].
    Mendoza I; Moleiro F; Marques J
    Arq Bras Cardiol; 1992 Jul; 59(1):3-4. PubMed ID: 1341144
    [No Abstract]   [Full Text] [Related]  

  • 22. [Chagas' cardiopathy. Experimental models].
    Amorim DS
    Arq Bras Cardiol; 1984 Apr; 42(4):243-7. PubMed ID: 6391435
    [No Abstract]   [Full Text] [Related]  

  • 23. Autoantibodies in Chagas' cardiomyopathy and arrhythmias.
    Chiale PA; Ferrari I
    Autoimmunity; 2001; 34(3):205-10. PubMed ID: 11908779
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of QTc interval dispersion in patients with chronic heart failure secondary to Chagas-Hypertensive cardiomyopathy.
    Pinheiro MB; Bestetti RB; Cordeiro JA
    Int J Cardiol; 2007 Sep; 121(1):93-4. PubMed ID: 17126936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas' patients.
    Wallukat G; Muñoz Saravia SG; Haberland A; Bartel S; Araujo R; Valda G; Duchen D; Diaz Ramirez I; Borges AC; Schimke I
    J Am Coll Cardiol; 2010 Feb; 55(5):463-8. PubMed ID: 20117461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle sympathetic nerve activity in patients with Chagas' disease.
    Negrão CE; Santos AC; Rondon MU; Franco FG; Ianni B; Rochitte CE; Braga AM; Oliveira MT; Mady C; Barretto AC; Middlekauff HR
    Int J Cardiol; 2009 Nov; 137(3):252-9. PubMed ID: 18723231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exercise testing in the latent phase of Chagas' disease.
    Pereira MH; Brito FS; Ambrose JA; Pereira CB; Levi GC; Neto VA; Martinez EE
    Clin Cardiol; 1984 May; 7(5):261-5. PubMed ID: 6424992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chagas' disease and tachycardiomyopathy].
    Brugada P
    Arq Bras Cardiol; 1991 Jan; 56(1):5-7. PubMed ID: 1872709
    [No Abstract]   [Full Text] [Related]  

  • 29. [Patients suffering dilated chagasic cardiopathy or non chagasic cardiopathy show an increased levels of tumor necrosis factor alpha].
    D'Angelo-Mendoza E; Rodríguez-Bonfante C; Camacho I; Martínez J; Perdomo T; Cabrera A; Bonfante-Cabarcas R
    Invest Clin; 2005 Sep; 46(3):229-40. PubMed ID: 16152779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical aspects of the Chagas' heart disease.
    Punukollu G; Gowda RM; Khan IA; Navarro VS; Vasavada BC
    Int J Cardiol; 2007 Feb; 115(3):279-83. PubMed ID: 16769134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of a risk score for predicting death in Chagas' heart disease.
    Rassi A; Rassi A; Little WC; Xavier SS; Rassi SG; Rassi AG; Rassi GG; Hasslocher-Moreno A; Sousa AS; Scanavacca MI
    N Engl J Med; 2006 Aug; 355(8):799-808. PubMed ID: 16928995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maximal functional capacity in patients with Chagas' cardiomyopathy without congestive heart failure.
    Mady C; Ianni BM; Arteaga E; Salemi VM; de Carvalho Frimm C
    J Card Fail; 2000 Sep; 6(3):220-4. PubMed ID: 10997748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Basic causes of death in elderly patients with Chagas' disease].
    de Menezes M; Rocha A; da Silva AC; da Silva AM
    Arq Bras Cardiol; 1989 Feb; 52(2):75-8. PubMed ID: 2512897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of sympathetic activation on heart rate variability in Chagas' patients.
    Guzzetti S; Josa D; Pecis M; Bonura L; Prosdocimi M; Malliani A
    J Auton Nerv Syst; 1990 Jul; 30 Suppl():S79-81. PubMed ID: 2212496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weekly electrocardiographic pattern in mice infected with two different Trypanosoma cruzi strains.
    Bustamante JM; Rivarola HW; Fretes R; Paglini-Oliva PA
    Int J Cardiol; 2005 Jul; 102(2):211-7. PubMed ID: 15982487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis of cardiac neuro-myopathy in Chagas' disease and the role of the autonomic nervous system.
    Iosa D; Dequattro V; Lee DD; Elkayam U; Caeiro T; Palmero H
    J Auton Nerv Syst; 1990 Jul; 30 Suppl():S83-7. PubMed ID: 2212497
    [No Abstract]   [Full Text] [Related]  

  • 37. Arrhythmias associated with Chagas' heart disease.
    Elizari MV
    Card Electrophysiol Rev; 2002 Feb; 6(1-2):115-9. PubMed ID: 11984031
    [No Abstract]   [Full Text] [Related]  

  • 38. A model of cardiac arrhythmias and sudden death: cantharidin-induced toxic cardiomyopathy.
    Rabkin SW; Friesen JM; Ferris JA; Fung HY
    J Pharmacol Exp Ther; 1979 Jul; 210(1):43-50. PubMed ID: 448646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noncompaction of the myocardium, Chagas' disease and dysfunction: a case report.
    Mello RP; Szarf G; Nakano E; Dietrich C; Cirenza C; Paola AA
    Arq Bras Cardiol; 2010 Jul; 95(1):e4-6. PubMed ID: 20694397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A risk score for predicting death in Chagas' heart disease.
    Kamath SA; Drazner MH
    N Engl J Med; 2006 Dec; 355(23):2489; author reply 2490-1. PubMed ID: 17162762
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.